Victory Square reports Q1 revenue of $24.9M and net income of $3.9M, driven by healthcare platform growth.

Victory Square Technologies announced Q1 2026 financial results with revenue rising to $24.9 million and net income reaching $3.9 million, primarily driven by growth in its healthcare platform Hydreight Technologies. The company also advanced its biotech subsidiary Insu Therapeutics' peptide delivery program and launched pet health initiatives through Pawsible Ventures. Victory Square plans to continue supporting portfolio growth and exploring monetization opportunities while maintaining disciplined capital allocation.